BLOOMBERG BUSINESSWEEK: A US company will next month report the results of its study of abiraterone acetate plus prednisone for the treatment of patients with metastatic advanced prostate cancer, also called castration-resistant prostate cancer. READ MORE>
Posts Tagged ‘Bloomberg Businessweek’
US conference will hear how immunotherapy drugs for prostate and other cancers have advanced
Posted in Uncategorized, tagged advanced prostate cancer, American Society of Clinical Oncology, Bloomberg Businessweek, cancer research, catheter, comparison of treatments, immunotherapy drugs, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, Provenge treatment on May 29, 2010| Leave a Comment »
BLOOMBERG BUSINESSWEEK: A wave of new immunotherapy drugs may help turn some lethal cancers into manageable chronic diseases. READ MORE>
Beginning on June 4, at the American Society of Clinical Oncology conference, the world’s biggest gathering of cancer doctors and drug and biotech companies will show how medicines now being developed will provoke the immune system to kill cancer cells.
Prostablog 